Health and Medicine

August 7, 2014

Conn lands Javits Neuroscience Investigator award

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders.

By Bill Snyder
August 7, 2014

Novel treatment strengthens bones in genetic disease

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.

By Leigh MacMillan
August 7, 2014

Study tracks new end-stage renal disease therapy

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

By Kathy Whitney
August 6, 2014

Low selenium and lung cancer

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.

By Yan Su
August 5, 2014

Technique brings spinal cord neural signaling into focus

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.

By Bill Snyder
August 5, 2014

Drug discovery clues in network map

Vanderbilt investigators have constructed a network map that could guide the development of new targeted cancer therapies.

By Bill Snyder
August 1, 2014

Anti-inflammatory protein “rheostat” sheds light on leaky blood vessels

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.
By Emily Poulin
July 31, 2014

Doris Duke awards enhance clinical research training

Vanderbilt University’s Cyndya Shibao, M.D., MSCI, has received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
By Bill Snyder
July 31, 2014

Grant bolsters biomedical ethics efforts in Mozambique

Vanderbilt University researchers have received a five-year, $1.2 million grant from the Fogarty International Center of the National Institutes of Health (NIH) to strengthen research ethics capacity in Mozambique.
By VUMC News and Communications
July 31, 2014

VICC investigators land Komen breast cancer research grants

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation.
By VUMC News and Communications
July 31, 2014

New target for breast cancer therapy

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics.
By Leigh MacMillan
July 25, 2014

Treatments for frog fungus

The fungicide amphotericin B may be a useful treatment for a frog fungus that is killing amphibians worldwide.
By Leigh MacMillan
July 24, 2014

Team spots trigger for rare diarrheal disease in infants

Researchers at Vanderbilt University, the University of Arizona and Phoenix Children’s Hospital have discovered what triggers a rare but devastating diarrheal disease in newborns that is fatal without intravenous feeding or intestinal transplant.
By Bill Snyder
1 … 133 134 135 136 137 … 192